US Stock Movement: ORIC Pharmaceuticals surges on October 15 as JPMorgan raises target price and innovative oncology drugs
Bitget异动解读2026/10/15 20:00ORIC Pharmaceuticals Surge on October 15 Explained
Keywords: JPMorgan raises target price, Innovative oncology drugs
Date unspecified, JPMorgan maintains a Buy rating and raises ORIC's target price from $23 to $26.
(Disclaimer: This content is generated by AI technology based on publicly available information for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moody's expects Nike's revenue and profits to decline through fiscal year 2028
Tesla Vice President of Energy and Charging, Mike Snyder, resigns
Moody’s changes Nike’s outlook to negative and confirms its A2 rating
Crypto prices
More
